Trade BVNRY stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Bavarian Nordic A/S Sponsored ADR (Denmark) (BVNRY) is trading at US$10.61, up 0.47% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$2.48B. Over the past 52 weeks, BVNRY has traded between US$8.67 and US$13.00. On Syfe you can trade BVNRY with $0 commission and add it to your watchlist.
| Previous close | US$10.56 |
|---|---|
| Market cap | US$2.48B |
| 52-week range | US$8.67 – US$13.00 |
| Volume | 1.03K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Bavarian Nordic A/S Sponsored ADR (Denmark)
Bavarian Nordic A/S engages in the business of developing, manufacturing, and commercializing cancer immunotherapies and vaccines for infectious diseases. The firm is involved in cancer immunotherapy including cancer pipeline, which focuses on therapeutic vaccines for breast, lung, ovarian, and prostate cancer. The company was founded on July 1, 1992 and is headquartered in Hellerup, Denmark.
Bavarian Nordic A/S Sponsored ADR (Denmark) (BVNRY) stock is trading at US$10.61, +0.47% from the previous close of US$10.56.
The market cap for Bavarian Nordic A/S Sponsored ADR (Denmark) (BVNRY) stock is approximately US$2.48B.
The 52-week high for Bavarian Nordic A/S Sponsored ADR (Denmark) (BVNRY) stock is US$13.00.
The 52-week low for Bavarian Nordic A/S Sponsored ADR (Denmark) (BVNRY) stock is US$8.67.
Bavarian Nordic A/S Sponsored ADR (Denmark) (BVNRY) does not currently pay a dividend.
Stay on top of BVNRY
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
